AFAP1L2 and prostate carcinoma: XB130 mRNA (Figure 2A) and protein (Figure 2B) levels were detected in prostate cancer cell line 22RV1, LNCap, DU145, PC3, which showed that XB130 expressed in four prostate cancer cell lines at different levels.